CDC14B

Chr 9

cell division cycle 14B

Also known as: CDC14B3, Cdc14B1, Cdc14B2, hCDC14B

This dual-specificity phosphatase regulates the G2 DNA damage checkpoint by dephosphorylating key cell cycle proteins including FZR1/CDH1 and tumor suppressor p53, preventing entry into mitosis following DNA damage. The gene is highly constrained against loss-of-function variants, but no established Mendelian diseases have been associated with CDC14B mutations to date. Further research is needed to determine if pathogenic variants in this gene cause human disease.

OMIMResearchSummary from RefSeq, UniProt
LOEUF 0.34
Clinical SummaryCDC14B
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.94). One damaged copy is likely sufficient to cause disease.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.34LOEUF
pLI 0.943
Z-score 4.07
OE 0.15 (0.070.34)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
1.01Z-score
OE missense 0.82 (0.740.92)
217 obs / 263.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.15 (0.070.34)
00.351.4
Missense OE0.82 (0.740.92)
00.61.4
Synonymous OE0.93
01.21.6
LoF obs/exp: 4 / 26.7Missense obs/exp: 217 / 263.3Syn Z: 0.49

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

CDC14B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →